Name: Glenmark launches first oral coronavirus drug in India called FabiFlu
Brand: businessinsider.in
SKU: businessinsider-in-7
Availability: OnlineOnly

critic

Glenmark launches first oral coronavirus drug in India called FabiFlu

preview

Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19. The Mumbai-based drug firm had on Friday received manufacturing and marketing approval from the Drugs Controller General of India (DCGI).FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in a statement."This approval comes at a time when cases in India are spiralling like never before, putting a tremendous pressure on our healthcare system," Glenmark Pharmaceuticals Chairman and Managing Director Glenn Saldanha said.The company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer patients in India a much needed and timely therapy option, he added.SEE ALSO:{{}}Email addressEnter captchaBy clicking ‘Sign up’, you agree to receive marketing emails from Insider as well as other partner offers and accept our and Copyright © 2022. Times Internet Limited. All rights reserved.For reprint rights. Times Syndication Service.

Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19. The Mumbai-based drug firm had on Friday received manufacturing and marketing approval from the Drugs Controller General of India (DCGI).FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in a statement."This approval comes at a time when cases in India are spiralling like never before, putting a tremendous pressure on our healthcare system," Glenmark...

public

Business Insider India

Intelligence for India's next generation.

businessinsider.in

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Glenmark launches first oral coronavirus drug in India called FabiFlu

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS